1. Home
  2. WNW vs SBFM Comparison

WNW vs SBFM Comparison

Compare WNW & SBFM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Meiwu Technology Company Limited

WNW

Meiwu Technology Company Limited

BUY

Current Price

$2.36

Market Cap

4.5M

ML Signal

BUY

Logo Sunshine Biopharma Inc.

SBFM

Sunshine Biopharma Inc.

BUY

Current Price

$0.42

Market Cap

4.3M

Sector

Health Care

ML Signal

BUY

Company Overview

Basic Information
Metric
WNW
SBFM
Founded
2018
2006
Country
China
United States
Employees
N/A
N/A
Industry
Catalog/Specialty Distribution
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.5M
4.3M
IPO Year
2019
2008

Fundamental Metrics

Financial Performance
Metric
WNW
SBFM
Price
$2.36
$0.42
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
49.2K
★ 127.8K
Earning Date
11-04-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
★ $36,305,891.00
Revenue This Year
N/A
$1.23
Revenue Next Year
N/A
$22.44
P/E Ratio
$1.14
★ N/A
Revenue Growth
N/A
★ 4.11
52 Week Low
$0.05
$0.25
52 Week High
$13.52
$3.05

Technical Indicators

Market Signals
Indicator
WNW
SBFM
Relative Strength Index (RSI) 45.15 16.14
Support Level $2.30 $0.27
Resistance Level $2.69 $1.28
Average True Range (ATR) 0.13 0.08
MACD 0.01 -0.03
Stochastic Oscillator 11.69 2.73

Price Performance

Historical Comparison
WNW
SBFM

About WNW Meiwu Technology Company Limited

Meiwu Technology Co Ltd operates as an online food retail store and franchise restaurants in China. The products offered include green food, organic food, intangible cultural heritage food products, agricultural products bearing geographical indications, and pollution-free products. It operates in three segments including Clean Food platform, Skincare products & service and Technical Service. The company generates the majority of its revenue from Technical services.

About SBFM Sunshine Biopharma Inc.

Sunshine Biopharma Inc is a pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, including oncology and antivirals. Through its subsidiaries, the company has various generic prescription drugs on the market in Canada and is also involved in developing and selling OTC supplements. In addition, the company is conducting a proprietary drug development program, which is comprised of K1.1 mRNA targeted for liver cancer and SBFM-PL4, PLpro protease inhibitor for SARS Coronavirus infections.

Share on Social Networks: